<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50161</article-id><article-id pub-id-type="doi">10.7554/eLife.50161</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Metabolic modulation regulates cardiac wall morphogenesis in zebrafish</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-149433"><name><surname>Fukuda</surname><given-names>Ryuichi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0281-5161</contrib-id><email>Ryuichi.Fukuda@mpi-bn.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149436"><name><surname>Aharonov</surname><given-names>Alla</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-95066"><name><surname>Ong</surname><given-names>Yu Ting</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3407-2515</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149437"><name><surname>Stone</surname><given-names>Oliver A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-114964"><name><surname>El-Brolosy</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20399"><name><surname>Maischein</surname><given-names>Hans-Martin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80708"><name><surname>Potente</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27949"><name><surname>Tzahor</surname><given-names>Eldad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5212-9426</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7189"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0382-0026</contrib-id><email>Didier.Stainier@mpi-bn.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Developmental Genetics</institution><institution>Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Ludwigstrasse</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Molecular Cell Biology</institution><institution>Weizmann Institute of Science</institution><addr-line><named-content content-type="city">Rehovot</named-content></addr-line><country>Israel</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Angiogenesis &amp; Metabolism Laboratory</institution><institution>Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Ludwigstrasse</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Reviewing Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Physiology, Anatomy and Genetics, BHF Centre of Research Excellence, University of Oxford, Oxford, United Kingdom</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e50161</elocation-id><history><date date-type="received" iso-8601-date="2019-07-12"><day>12</day><month>07</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-20"><day>20</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Fukuda et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Fukuda et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50161-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.50163"/><related-article ext-link-type="doi" id="ra2" related-article-type="commentary" xlink:href="10.7554/eLife.54665"/><abstract><p>During cardiac development, cardiomyocytes form complex inner wall structures called trabeculae. Despite significant investigation into this process, the potential role of metabolism has not been addressed. Using single cell resolution imaging in zebrafish, we find that cardiomyocytes seeding the trabecular layer actively change their shape while compact layer cardiomyocytes remain static. We show that Erbb2 signaling, which is required for trabeculation, activates glycolysis to support changes in cardiomyocyte shape and behavior. Pharmacological inhibition of glycolysis impairs cardiac trabeculation, and cardiomyocyte-specific loss- and gain-of-function manipulations of glycolysis decrease and increase trabeculation, respectively. In addition, loss of the glycolytic enzyme pyruvate kinase M2 impairs trabeculation. Experiments with rat neonatal cardiomyocytes in culture further support these observations. Our findings reveal new roles for glycolysis in regulating cardiomyocyte behavior during cardiac wall morphogenesis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>zebrafish</kwd><kwd>trabeculation</kwd><kwd>heart development</kwd><kwd>cardiomyocytes</kwd><kwd>metabolism</kwd><kwd>glycolysis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><award-id>Open-access funding</award-id><principal-award-recipient><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>3D single cell imaging and genetic analyses reveal a new role of cardiac metabolism in cardiac wall morphogenesis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During development, the heart undergoes a series of morphogenetic changes to form a functional cardiac wall structure (<xref ref-type="bibr" rid="bib39">Moorman and Christoffels, 2003</xref>; <xref ref-type="bibr" rid="bib53">Staudt and Stainier, 2012</xref>). The outer wall of the developing ventricle consists of compact layer cardiomyocytes (CMs), while the inner wall consists of complex muscular ridges, termed trabeculae, which facilitate efficient cardiac contraction and oxygenation of the cardiac wall prior to the formation of coronary vessels (<xref ref-type="bibr" rid="bib51">Sedmera et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Staudt and Stainier, 2012</xref>). Disruption of ventricular wall morphogenesis is associated with congenital cardiac malformations, the most common type of birth defects (<xref ref-type="bibr" rid="bib13">Fahed et al., 2013</xref>), yet the cellular and molecular mechanisms regulating this complex process remain unclear.</p><p>Neuregulin (NRG)/Erb-b2 receptor tyrosine kinase (ERBB) 2/4 signaling has been shown to be essential for cardiac trabeculation. <italic>Nrg1</italic>, <italic>Erbb2</italic> and <italic>Erbb4</italic> knockout mice (<xref ref-type="bibr" rid="bib16">Gassmann et al., 1995</xref>; <xref ref-type="bibr" rid="bib29">Lee et al., 1995</xref>; <xref ref-type="bibr" rid="bib37">Meyer and Birchmeier, 1995</xref>) and <italic>nrg2a</italic> (<xref ref-type="bibr" rid="bib48">Rasouli and Stainier, 2017</xref>) and <italic>erbb2</italic> (<xref ref-type="bibr" rid="bib31">Liu et al., 2010</xref>) mutant fish fail to form trabeculae. ERBBs are members of the epidermal growth factor (EGF) receptor tyrosine kinase family. NRGs are expressed by the endocardium (<xref ref-type="bibr" rid="bib5">Corfas et al., 1995</xref>; <xref ref-type="bibr" rid="bib37">Meyer and Birchmeier, 1995</xref>; <xref ref-type="bibr" rid="bib17">Grego-Bessa et al., 2007</xref>; <xref ref-type="bibr" rid="bib48">Rasouli and Stainier, 2017</xref>) and bind to ERBBs on CMs, triggering homo- or heterodimerization of ERBB family members and leading to activation of downstream pathways (<xref ref-type="bibr" rid="bib50">Sanchez-Soria and Camenisch, 2010</xref>). However, the targets of ERBB2 signaling that regulate CM behavior during trabeculation have not been identified.</p><p>Cardiac metabolism has been extensively studied in adult animals due to its central role in supplying energy for cardiac contraction (<xref ref-type="bibr" rid="bib10">Doenst et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Kolwicz et al., 2013</xref>). Adult CMs rely mostly on fatty acids as an energy substrate, and they are oxidized in mitochondria to generate ATP (<xref ref-type="bibr" rid="bib12">Ellen Kreipke et al., 2016</xref>). Under conditions of hypertrophic or ischemic stress, CMs revert to glycolytic metabolism (<xref ref-type="bibr" rid="bib10">Doenst et al., 2013</xref>), which is characteristic of embryonic cardiomyocytes and uses glucose as a fuel. Besides its role in energy generation, little is known about the role of metabolism during cardiac development.</p><p>Here, using high-resolution single cell imaging in zebrafish, we first show that developing CMs undergo extensive shape changes during the formation of the trabecular layer. By modulating glucose metabolism pharmacologically, we show that glycolysis regulates these processes. Using CM-specific loss- and gain-of-function models as well as mutant animals compromised in their glycolytic activity, we identify a role for glycolysis in cardiac wall morphogenesis. This study provides new insights into the role of cardiac metabolism in cardiac development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Cardiomyocytes that enter the trabecular layer exhibit distinct behaviors</title><p>During cardiac trabeculation in zebrafish and mouse, CMs delaminate from the compact layer to seed the trabecular layer (<xref ref-type="bibr" rid="bib31">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="bib60">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Staudt et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Jiménez-Amilburu et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Del Monte-Nieto et al., 2018</xref>). Although CM behavior during trabeculation has been observed in zebrafish (<xref ref-type="bibr" rid="bib52">Staudt et al., 2014</xref>; <xref ref-type="bibr" rid="bib2">Cherian et al., 2016</xref>), the 3D morphology of single cardiomyocytes during the trabeculation process needs to be further explored. To this end, we performed 3D time-course imaging using chimeric hearts generated by cell transplantation. To label CM membranes and nuclei with EGFP and DsRed2 respectively, we used <italic>Tg(myl7:EGFP-HRAS); Tg(myl7:nDsRed2)</italic> cells as donors (<xref ref-type="fig" rid="fig1">Figure 1a</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). We found that delaminating CMs exhibit morphological changes as well as rearrangements of contact sites (<xref ref-type="fig" rid="fig1">Figure 1b–c”</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b–d”</xref>; <xref ref-type="video" rid="fig1video1">Figure 1—videos 1</xref> and <xref ref-type="video" rid="fig1video2">2</xref>), while CMs remaining in the compact layer do not exhibit such changes (<xref ref-type="fig" rid="fig1">Figure 1d–e”</xref>). To examine cell-cell junctions during delamination, we analyzed N-cadherin (Cdh2), a major adherens junction component, at single cell resolution, and to this end used <italic>Tg(myl7:EGFP-HRAS); Tg(myl7:cdh2-tdTomato)</italic> cells as donors (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1e</xref>). We observed that N-cadherin localizes to protruding membranes in delaminating CMs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1f–g”</xref>) and to the lateral membranes of compact layer CMs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1h–i”</xref>), in agreement with a previous report (<xref ref-type="bibr" rid="bib2">Cherian et al., 2016</xref>). Next, we analyzed sarcomere structure during delamination using <italic>Tg(myl7:LIFEACT-GFP); Tg(myl7:nDsRed2)</italic> cells as donors. We found that CMs display partial sarcomere disassembly in their protrusions when entering the trabecular layer (<xref ref-type="fig" rid="fig1">Figure 1f–g”</xref>). These data indicate that delaminating CMs exhibit distinct behaviors including dynamic cell shape changes.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Cardiomyocyte behavior during cardiac trabeculation.</title><p>(<bold>a</bold>) Schematic of the transplantation experiment. (<bold>b–e</bold>) 3D time-course images of chimeric hearts; magnified view (<bold>b’, c’, d’, e’</bold>) of area in white boxes and Y-Z plane images (<bold>b”, c”, d”, e”</bold>) along white dashed lines (<bold>b’, c’, d’, e’</bold>). CMs initially in the compact layer (<bold>b’, b”</bold>) enter the trabecular layer (<bold>c’, c”</bold>) exhibiting morphological changes and membrane protrusions (c’; arrowheads; <italic>n</italic> = 5 CMs); CMs remaining in the compact layer (<bold>d’, d”, e’, e”</bold>) do not exhibit obvious morphological changes (<italic>n</italic> = 5 CMs). The same CMs are shown at 126 and 175 hpf as indicated in the images. (<bold>f, g</bold>) 3D time-course images of chimeric heart; magnified view (<bold>f’, f”, g’, g”</bold>) of area in white boxes. CMs entering the trabecular layer exhibit partial disassembly of their sarcomeres (g’; arrowhead). Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cardiomyocytes change morphology and exhibit cell-cell junction rearrangements when entering the trabecular layer.</title><p>(<bold>a</bold>) Schematic of the transplantation experiment. (<bold>b</bold>) Circularity analysis of CMs in the compact and trabecular layers (<italic>n</italic> = 7–9 CMs from 3 to 5 ventricles). (<bold>c–c”</bold>) 3D images of chimeric hearts; Y-Z plane images (<bold>d–d”</bold>) along white dashed line (<bold>c”</bold>). A host-derived CM entering the trabecular layer exhibits membrane protrusions (c, d, c’, d’; arrows). (<bold>e</bold>) Schematic of the transplantation experiment. (<bold>f–f”, h–h”</bold>) 3D images of chimeric hearts; Y-Z plane images (<bold>g–g”, i–i”</bold>). A CM entering the trabecular layer exhibits N-cadherin localization in protruding membranes (g, g’; arrows), while a CM remaining in the compact layer exhibits lateral localization of N-cadherin (i, i’; arrowheads). L, cardiac lumen. Error bars, s.e.m.; **p&lt;0.001 by two-tailed unpaired <italic>t</italic>-test. Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig1-figsupp1-v2.tif"/></fig><media id="fig1video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-50161-fig1-video1.mp4"><label>Figure 1—video 1.</label><caption><title>Z-stack images of 126 hpf CMs related to <xref ref-type="fig" rid="fig1">Figure 1b’</xref>.</title></caption></media><media id="fig1video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-50161-fig1-video2.mp4"><label>Figure 1—video 2.</label><caption><title>Z-stack images of 175 hpf CMs related to <xref ref-type="fig" rid="fig1">Figure 1c’</xref>.</title></caption></media></fig-group></sec><sec id="s2-2"><title>ERBB2 signaling activates glycolysis in cardiomyocytes</title><p>To gain additional insight into the molecular mechanisms that regulate trabeculation, we focused on ERBB2 signaling which is essential for this process in both mouse (<xref ref-type="bibr" rid="bib16">Gassmann et al., 1995</xref>; <xref ref-type="bibr" rid="bib29">Lee et al., 1995</xref>; <xref ref-type="bibr" rid="bib37">Meyer and Birchmeier, 1995</xref>) and zebrafish (<xref ref-type="bibr" rid="bib31">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Peshkovsky et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Rasouli and Stainier, 2017</xref>). In order to identify targets of ERBB2 signaling, we analyzed protein expression in a CM-specific transgenic mouse model inducibly expressing a constitutively active form of ERBB2 (CAERBB2) (<xref ref-type="bibr" rid="bib11">D’Uva et al., 2015</xref>). We found that upon CAERBB2 overexpression (OE), several glycolytic enzymes were upregulated, while mitochondrial proteins and oxidative phosphorylation (OXPHOS)-related enzymes were downregulated (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). We also tested the effects of <italic>Erbb2</italic> OE, which like <italic>CAErbb2</italic> OE, activates downstream signaling (<xref ref-type="bibr" rid="bib43">Pedersen et al., 2009</xref>), on the expression of glycolytic enzyme genes in rat neonatal CMs, and found that many of them were upregulated (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). Notably, we found that <italic>Erbb2</italic> OE in rat neonatal CMs greatly upregulated the levels of pyruvate kinase M2 (PKM2), a key glycolytic enzyme, (<xref ref-type="fig" rid="fig2">Figure 2b and c</xref>), and increased glycolytic activity as evidenced by measuring extracellular acidification rate (ECAR) (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). NRG1 stimulation also activated glycolysis in rat neonatal CMs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>). These findings are also supported by a study analyzing changes in mRNA levels in <italic>caErbb2</italic> OE mouse hearts (<xref ref-type="bibr" rid="bib21">Honkoop et al., 2019</xref>). Moreover, we treated zebrafish embryos with an Erbb2 inhibitor (<xref ref-type="fig" rid="fig2">Figure 2e</xref>), which has been shown to severely affect trabeculation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>) (<xref ref-type="bibr" rid="bib31">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Peshkovsky et al., 2011</xref>), and found that the cardiac expression of glycolytic enzyme genes was downregulated (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). Altogether, these data indicate that ERBB2 signaling activates glycolysis in CMs.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>ERBB2 signaling activates glycolysis in cardiomyocytes.</title><p>(<bold>a</bold>) qPCR analysis of mRNA levels of glycolytic enzyme genes in control and <italic>Erbb2</italic> overexpressing (OE) rat neonatal CMs (<italic>n</italic> = 3). Error bars, s.e.m. (<bold>b</bold>) Staining for PKM2, CTNI and DNA (DAPI) in control and <italic>Erbb2</italic> OE rat neonatal CMs; arrowheads point to PKM2+ CMs. (<bold>c</bold>) Western blot analysis of PKM2 levels in control and <italic>Erbb2</italic> OE rat neonatal CMs. (<bold>d</bold>) Extracellular acidification rate (ECAR) analysis in control and <italic>Erbb2</italic> OE rat neonatal CMs; glycolytic capacity shown on the right (<italic>n</italic> = 7). Error bars, s.d. (<bold>e</bold>) qPCR analysis of mRNA levels of glycolytic enzyme genes in DMSO and Erbb2 inhibitor treated zebrafish hearts (<italic>n</italic> = 3). Error bars, s.e.m.; *p&lt;0.05 and **p&lt;0.001 by two-tailed unpaired <italic>t</italic>-test. NS, not significant. Scale bar, 20 μm.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Mass spectrometry data.</title><p>P7 WT and CAERBB<italic>2</italic> OE mouse hearts were isolated and protein expression levels analyzed by mass spectrometry. All presented proteins are statistically significant at p&lt;0.05.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50161-fig2-data1-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Primer sequences for qPCR analysis.</title><p>Primer sequences used in <xref ref-type="fig" rid="fig2">Figure 2a and e</xref>.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50161-fig2-data2-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Mean Ct values of qPCR analysis in <xref ref-type="fig" rid="fig2">Figure 2a and e</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50161-fig2-data3-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>NRG1/ERBB2 signaling activates glycolysis in CMs.</title><p>(<bold>a</bold>) ECAR analysis in control and NRG1 treated rat neonatal CMs; glycolytic capacity shown on the right (<italic>n</italic> = 7). (<bold>b</bold>) Confocal images (mid-sagittal sections) of 77 hpf zebrafish hearts treated with DMSO or Erbb2 inhibitor; magnified view of area in white boxes shown below; arrowheads point to CMs in the trabecular layer. Error bars, s.d.; *p&lt;0.05 by two-tailed unpaired <italic>t</italic>-test. Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Uncropped images related to western blotting data.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig2-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Glycolysis regulates cardiomyocyte delamination during development</title><p>In order to analyze the role of glycolysis during trabeculation, we first focused on pyruvate metabolism. The pyruvate dehydrogenase complex (PDC) catalyzes the conversion of pyruvate to acetyl-coenzyme A (acetyl-CoA), which enters the tricarboxylic acid cycle (<xref ref-type="bibr" rid="bib61">Zhang et al., 2014</xref>). Pyruvate dehydrogenase kinases (PDKs) inhibit PDC activity and enhance glycolysis in CMs (<xref ref-type="bibr" rid="bib62">Zhao et al., 2008</xref>) and cancer cells (<xref ref-type="bibr" rid="bib26">Koukourakis et al., 2005</xref>; <xref ref-type="bibr" rid="bib32">Lu et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Leclerc et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Peng et al., 2018</xref>), thereby regulating the switch between glycolysis and OXPHOS (<xref ref-type="bibr" rid="bib61">Zhang et al., 2014</xref>). Our analyses show that ERBB2 signaling positively regulates <italic>Pdk3</italic> gene as well as protein expression (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Thus, we hypothesized that PDK3 was one of the key enzymes regulating glycolysis in delaminating CMs in response to Erbb2 signaling. Consistent with this model, we found that the PDK inhibitor dichloroacetate (DCA) led to a significant reduction in the number of CMs in the trabecular layer (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Of note, this phenotype is similar to the one caused by Erbb2 inhibition (<xref ref-type="fig" rid="fig3">Figure 3a</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Glycolysis regulates cardiac trabeculation.</title><p>(<bold>a</bold>) Confocal images (mid-sagittal sections) of 77 hpf hearts treated with DMSO, dichloroacetate (DCA) or Erbb2 inhibitor; magnified view of area in white boxes shown below; arrowheads point to CMs in the trabecular layer; percentage of CMs in the trabecular layer shown on the right (<italic>n</italic> = 5–7 ventricles). (<bold>b</bold>) Confocal images (mid-sagittal sections) of 77 hpf <italic>Tg(myl7:BFP-CAAX)</italic> alone or in combination with <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)</italic> or <italic>Tg(myl7:pdk3b-P2A-tdTomato)</italic> hearts; magnified view of area in white boxes shown below; arrowheads point to CMs in the trabecular layer; percentage of CMs in the trabecular layer shown on the right (<italic>n</italic> = 5–7 ventricles). (<bold>c–e”</bold>) Staining for CTNI, N-cadherin and DNA (DAPI) in control (<bold>c</bold>), <italic>Pdk3</italic> (<bold>d</bold>) and <italic>Erbb2</italic> (<bold>e</bold>) OE rat neonatal CMs; magnified view of area in yellow (<bold>c’, d’, e’</bold>) and white (<bold>c”, d”, e”</bold>) boxes; percentage of CMs exhibiting membrane protrusions shown on the right (<italic>n</italic> = 3 individual experiments; each value corresponds to an average of 30 CMs). <italic>Pdk3</italic> and <italic>Erbb2</italic> OE causes rat neonatal CMs to exhibit membrane protrusions (d’, e’; arrows) and cell-cell junction rearrangements (d’, e’; arrowheads). Error bars, s.e.m.; *p&lt;0.05 and **p&lt;0.001 by ANOVA followed by Tukey’s HSD test. Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Cardiomyocyte proliferation does not appear to be affected by modulation of glycolysis.</title><p>(<bold>a</bold>) Confocal images (mid-sagittal sections) of 131 hpf <italic>Tg(myl7:EGFP-HRAS)</italic> alone or in combination with <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)</italic> and of 131 hpf <italic>Tg(myl7:EGFP-HRAS); pkma2<sup>-/-</sup>; pkmb<sup>-/-</sup></italic> hearts; magnified view of area in white boxes shown below; arrowheads point to trabecular CMs; percentage of trabecular area shown on the right (<italic>n</italic> = 5 ventricles). (<bold>b</bold>) Confocal images (mid-sagittal sections) of 77 hpf <italic>Tg(myl7:mVenus-gmnn); Tg(myl7:BFP-CAAX)</italic> alone or in combination with <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)</italic> or <italic>Tg(myl7:pdk3b-P2A-tdTomato)</italic> hearts; arrowheads point to <italic>myl7:</italic>mVenus-Gmnn+ CMs; percentage of <italic>myl7:</italic>mVenus-Gmnn + CMs shown on the right (<italic>n</italic> = 5 ventricles). Error bars, s.e.m.; *p&lt;0.05 and **p&lt;0.001 by two-tailed unpaired <italic>t</italic>-test (<bold>a</bold>) or ANOVA followed by Tukey’s HSD test (<bold>b</bold>). NS, not significant. Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig3-figsupp1-v2.tif"/></fig></fig-group><p>We next focused on <italic>pyruvate dehydrogenase E1 alpha 1 subunit a</italic> (<italic>pdha1a</italic>), which encodes a catalytic subunit of the PDC. Analysis of CM-specific loss of <italic>Pdha1</italic> in mice has revealed the importance of PDC activity for OXPHOS (<xref ref-type="bibr" rid="bib55">Sun et al., 2016</xref>). We generated a <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)</italic> line to overexpress an activated form of Pdha1a in CMs. This activated form of Pdha1a (Pdha1aSTA) contains mutations in its phosphorylation sites and thus is not inhibited by PDK. As a result, glycolysis is reduced and OXPHOS enhanced, as previously shown in cancer cells (<xref ref-type="bibr" rid="bib20">Hitosugi et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Fan et al., 2014</xref>). Notably, larvae expressing this activated form of Pdha1a exhibited a significant decrease in the number of CMs in the trabecular layer (<xref ref-type="fig" rid="fig3">Figure 3b</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a</xref>). We also generated a <italic>Tg(myl7:pdk3b-P2A-tdTomato)</italic> line to overexpress <italic>pdk3b</italic> in CMs and thereby promotes glycolysis (<xref ref-type="bibr" rid="bib32">Lu et al., 2008</xref>), and found that these transgenic larvae exhibited a significant increase in the number of CMs in the trabecular layer (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). Next, we tested whether the modulation of glycolysis affected CM proliferation and found that <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)</italic> or <italic>Tg(myl7:pdk3b-P2A-tdTomato)</italic> larvae did not exhibit a significant change compared to WT in the percentage of mVenus-gmnn+ CMs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b</xref>). Furthermore, we examined whether the modulation of glycolysis affected CM morphology in rat neonatal CMs in culture and found that <italic>Pdk3</italic> overexpression led to the induction of membrane protrusions (<xref ref-type="fig" rid="fig3">Figure 3d and d’</xref>), as well as cell-cell junction rearrangements (<xref ref-type="fig" rid="fig3">Figure 3d–d”</xref>). Similar effects were also observed following <italic>Erbb2</italic> overexpression (<xref ref-type="fig" rid="fig3">Figure 3e–e”</xref>). Together, these data suggest that CM morphological changes regulated by glycolysis are important for delamination.</p><p>In order to further assess the role of glycolysis in trabeculation, we focused on zebrafish <italic>pkm2</italic> to analyze a glycolytic enzyme mutant model. Loss of <italic>PKM2</italic> has been shown to impair glycolysis in endothelial cells (<xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref>), and PKM2 expression has been associated with glycolysis and cell growth in cancer cells (<xref ref-type="bibr" rid="bib4">Christofk et al., 2008</xref>). Moreover, in rat neonatal CMs, <italic>Erbb2</italic> OE upregulated <italic>Pkm2</italic> (<xref ref-type="fig" rid="fig2">Figure 2b and c</xref>). Mammalian <italic>Pkm</italic> encodes two splice variants (M1 and M2 isoforms); PKM2 plays an important role in glycolysis, while PKM1 promotes OXPHOS (<xref ref-type="bibr" rid="bib4">Christofk et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Lunt et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Zheng et al., 2016</xref>). Zebrafish <italic>pkma2</italic>, a splice variant of <italic>pkma</italic>, and <italic>pkmb</italic> are the orthologues of mammalian <italic>Pkm2</italic> (<xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref>). During early development, <italic>pkma</italic> is expressed in the heart, head, spinal cord and blood vessels, while <italic>pkmb</italic> is highly expressed in the somites (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a</xref>). At later stages, <italic>pkmb</italic> becomes clearly expressed in the heart (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b</xref>; <xref ref-type="bibr" rid="bib19">Gunawan et al., 2019</xref>). We examined <italic>pkma2; pkmb</italic> double mutants in which Pkma1, which drives pyruvate metabolism via OXPHOS, remains intact, and found that loss of <italic>pkma2</italic> and <italic>pkmb</italic> impaired trabeculation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c</xref>). We did not find evidence for increased CM apoptosis in <italic>pkma2; pkmb</italic> double mutants compared to WT (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1d</xref>). In order to examine the CM-specific role of <italic>pkma2</italic> and <italic>pkmb</italic> in trabeculation, we performed cell transplantation experiments whereby <italic>pkma2; pkmb</italic> double heterozygous and double mutant cells were transplanted into WT embryos (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). We found a significantly lower percentage of double mutant versus double heterozygous CMs in the trabecular layer of mosaic hearts (<xref ref-type="fig" rid="fig4">Figure 4b–c</xref>), indicating the importance of these genes in trabeculation. We also counted the number of trabecular CMs in these chimeric hearts and observed no significant deviation from WT (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1e</xref>). Altogether, these results indicate that glycolysis plays important and CM-autonomous roles during trabeculation.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of <italic>pkm2</italic> impairs cardiac trabeculation.</title><p>(<bold>a</bold>) Schematic of the transplantation experiment. (<bold>b, b’</bold>) 3D and mid-sagittal section images of chimeric hearts using <italic>pkma2<sup>+/-</sup>; pkmb<sup>+/-</sup>; Tg(myl7:EGFP-HRAS)</italic> (<bold>b</bold>) and <italic>pkma2<sup>-/-</sup>; pkmb<sup>-/-</sup>; Tg(myl7:EGFP-HRAS)</italic> (<bold>b’</bold>) cells as donors; magnified view of area in white boxes shown below. (<bold>c</bold>) Percentage of donor-derived trabecular CMs (<italic>n</italic> = 10 ventricles). Error bars, s.e.m.; *p&lt;0.05 by two-tailed unpaired <italic>t</italic>-test. Scale bars, 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Glycolytic enzymes regulate cardiac trabeculation.</title><p>(<bold>a</bold>) Analysis of <italic>pkma</italic> and <italic>pkmb</italic> mRNA expression by in situ hybridization; magnified view shown in the top right corner; arrows point to the heart. (<bold>b</bold>) Expression levels of <italic>pkma</italic> and <italic>pkmb</italic> in 52 hpf and seven dpf hearts as detected by microarray analysis. (<bold>c</bold>) Confocal images (mid-sagittal sections) of 77 hpf <italic>Tg(myl7:EGFP-HRAS); pkma2<sup>+/-</sup>; pkmb<sup>+/-</sup></italic> and <italic>Tg(myl7:EGFP-HRAS); pkma2<sup>-/-</sup>; pkmb<sup>-/-</sup></italic> hearts; magnified view of area in white boxes shown below; arrowheads point to CMs in the trabecular layer; percentage of CMs in the trabecular layer shown on the right (<italic>n</italic> = 5–7 ventricles). (<bold>d</bold>) TUNEL assay in WT and chimeric hearts using <italic>Tg(myl7:nDsRed2); pkma2<sup>-/-</sup>; pkmb<sup>-/-</sup></italic> cells as donors. As a positive control for the TUNEL assay, WT embryos were treated with DNase. (<bold>e</bold>) Percentage of trabecular CMs in WT and chimeric hearts using <italic>pkma2<sup>+/-</sup>; pkmb<sup>+/-</sup></italic> or <italic>pkma2<sup>-/-</sup>; pkmb<sup>-/-</sup></italic> cells as donors (<italic>n</italic> = 5 ventricles). Error bars, s.e.m.; *p&lt;0.05 by two-tailed unpaired <italic>t</italic>-test (<bold>c</bold>) or ANOVA followed by Tukey’s HSD test (<bold>e</bold>). Scale bars, 200 μm in a; 20 μm in c and d.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-fig4-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>During trabeculation, CMs exhibit membrane protrusions (<xref ref-type="bibr" rid="bib52">Staudt et al., 2014</xref>) and rearrange their cell-cell junctions (<xref ref-type="bibr" rid="bib2">Cherian et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Miao et al., 2019</xref>). Our 3D single CM imaging clearly reveals that CMs that enter the trabecular layer change their shape, similar to migrating cells, and lose cell-cell adhesion, indicating that they undergo phenotypic changes. Epithelial cells exhibit cellular plasticity as they change shape, and lose cell-cell adhesion and apicobasal polarity - a phenotypic transformation called epithelial to mesenchymal transition (EMT) (<xref ref-type="bibr" rid="bib41">Nieto, 2013</xref>; <xref ref-type="bibr" rid="bib58">Ye and Weinberg, 2015</xref>; <xref ref-type="bibr" rid="bib57">Varga and Greten, 2017</xref>). Recent studies suggest that endothelial cells can also undergo phenotypic changes towards mesenchymal-like cells (<xref ref-type="bibr" rid="bib36">Markwald et al., 1977</xref>; <xref ref-type="bibr" rid="bib59">Zeisberg et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Pearson, 2015</xref>; <xref ref-type="bibr" rid="bib8">Dejana et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Kovacic et al., 2019</xref>). Before the onset of trabeculation, compact layer CMs exhibit apicobasal polarity, and then some of them depolarize and subsequently delaminate to seed the trabecular layer (<xref ref-type="bibr" rid="bib24">Jiménez-Amilburu et al., 2016</xref>). Notably, ERBB2 signaling, which is essential for trabeculation (<xref ref-type="bibr" rid="bib29">Lee et al., 1995</xref>; <xref ref-type="bibr" rid="bib31">Liu et al., 2010</xref>), induces EMT in breast cancer cells (<xref ref-type="bibr" rid="bib1">Carpenter et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Ingthorsson et al., 2016</xref>). Altogether, these data indicate that during trabeculation CMs undergo an EMT-like process triggered by ERBB2 signaling.</p><p>Cardiac metabolism is essential for energy production to sustain continuous cardiac contractions (<xref ref-type="bibr" rid="bib10">Doenst et al., 2013</xref>). However, the role of metabolism during cardiac development remains unclear. Our study reveals that glycolysis regulates CM behavior during cardiac wall morphogenesis. Glycolysis enables rapid production of ATP to meet the high-energy demands of cell proliferation and migration in developing tissues, cancer cells and endothelial cells (<xref ref-type="bibr" rid="bib34">Lunt and Vander Heiden, 2011</xref>; <xref ref-type="bibr" rid="bib30">Liberti and Locasale, 2016</xref>; <xref ref-type="bibr" rid="bib47">Potente and Carmeliet, 2017</xref>). Moreover, glycolytic intermediates are utilized to produce biomass including proteins and nucleic acids, further supporting these processes (<xref ref-type="bibr" rid="bib7">DeBerardinis et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Potente and Carmeliet, 2017</xref>). In addition, excessive glycolysis is associated with EMT in cancer cells (<xref ref-type="bibr" rid="bib45">Peppicelli et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Huang and Zong, 2017</xref>; <xref ref-type="bibr" rid="bib40">Morandi et al., 2017</xref>). These findings indicate that glycolysis could regulate CM behavior in several different ways, and it will be interesting to dissect these processes further.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>pkma2<sup>s717</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Danio rerio</italic>)</td><td valign="top"><italic>pkmb<sup>s718</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Danio rerio</italic>)</td><td valign="top"><italic>pdk3b</italic></td><td valign="top"/><td valign="top">NM_001080688</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Danio rerio</italic>)</td><td valign="top"><italic>pdha1a</italic></td><td valign="top"/><td valign="top">NM_213393</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Rattus norvegicus</italic>)</td><td valign="top"><italic>Pdk3</italic></td><td valign="top"/><td valign="top">NM_001106581</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Homo sapiens</italic>)</td><td valign="top"><italic>ERBB2</italic></td><td valign="top"/><td valign="top">NM_004448</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">anti-Cardiac Troponin I (Goat polyclonal)</td><td valign="top">Abcam</td><td valign="top">AB_880622 <break/>Cat# ab56357</td><td valign="top">IF(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-PKM2 (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">AB_1904096 <break/>Cat# D78A4</td><td valign="top">IF(1:100) <break/>WB(1:1000)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sodium dichloroacetate</td><td valign="top">Sigma Aldrich</td><td valign="top">347795</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Zen 2012 (Blue edition)</td><td valign="top">Carl Zeiss Microscopy</td><td valign="top">Version 1.1.2.0</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Imaris x64</td><td valign="top">Bitplane</td><td valign="top">Version 9.3.0</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">DAPI stain</td><td valign="top">Sigma</td><td valign="top">D954</td><td valign="top">(1 µg/mL)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish</title><p>All zebrafish husbandry was performed under standard conditions in accordance with institutional (MPG) and national ethical and animal welfare guidelines. The following transgenic lines and mutants were used: <italic>Tg(myl7:EGFP-Has.HRAS)<sup>s883</sup></italic> (<xref ref-type="bibr" rid="bib6">D'Amico et al., 2007</xref>) abbreviated <italic>Tg(myl7:EGFP-HRAS)</italic>, <italic>Tg(myl7:LIFEACT-GFP)<sup>s974</sup></italic> (<xref ref-type="bibr" rid="bib49">Reischauer et al., 2014</xref>), <italic>Tg(−5.1myl7:DsRed2-NLS</italic>)<italic><sup>f2Tg</sup></italic> (<xref ref-type="bibr" rid="bib35">Mably et al., 2003</xref>) abbreviated <italic>Tg(myl7:nDsRed2)</italic>, <italic>Tg(kdrl:Has.HRAS-mCherry)<sup>s896</sup></italic> (<xref ref-type="bibr" rid="bib3">Chi et al., 2008</xref>) abbreviated <italic>Tg(kdrl:HRAS-mCherry)</italic>, <italic>Tg(myl7:cdh2-tdTomato)<sup>bns78</sup></italic> (<xref ref-type="bibr" rid="bib15">Fukuda et al., 2017</xref>), <italic>Tg(myl7:BFP-CAAX)<sup>bns193</sup></italic> (<xref ref-type="bibr" rid="bib18">Guerra et al., 2018</xref>), <italic>Tg(myl7:mVenus-Gemnn)<sup>ncv43Tg</sup></italic> (<xref ref-type="bibr" rid="bib24">Jiménez-Amilburu et al., 2016</xref>), <italic>pkma</italic>2<italic><sup>s717</sup></italic> (<xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref>) and <italic>pkmb<sup>s718</sup></italic> (<xref ref-type="bibr" rid="bib54">Stone et al., 2018</xref>). To generate <italic>Tg(myl7:pdk3b-P2A-tdTomato)<sup>bns365</sup></italic> and <italic>Tg(myl7:pdha1aSTA-P2A-tdTomato)<sup>bns366</sup></italic>, <italic>pdk3b</italic> (NM_001080688) and <italic>pdha1a</italic> (NM_213393) were isolated by RT-PCR and cloned under the control of the <italic>myl7</italic> promoter in a vector containing <italic>Tol2</italic> elements and two I-SceI restriction enzyme sites. The following primers were used to amplify the cDNA: <italic>pdk3b</italic> (forward 5’- <named-content content-type="sequence">AAGCAGACAGTGAACAAGCTTCCACCATGAAACTGTTTATCTGCCTACTG</named-content>-3’ and reverse 5’-<named-content content-type="sequence">TAGCTCCGCTTCCGTCGACTCTGTTGACTTTGTATGTGGAC</named-content>-3’); <italic>pdha1a</italic> (forward 5’-<named-content content-type="sequence">AAGCAGACAGTGAACAAGCTTCCACCATGAGAAAGATGCTAACCATAATT</named-content>-3’ and reverse 5’-<named-content content-type="sequence">TAGCTCCGCTTCCGTCGACGCTGATGGACTTGAGTTTG</named-content>-3’).</p><p>To generate the plasmid encoding an activated form of <italic>pdha1a</italic> (<italic>pdha1aSTA</italic>), the equivalent residues for human PDHA1 Ser293 and Tyr301 were replaced by alanine using the following primers: <italic>pdha1aSTA</italic> (forward 5’- <named-content content-type="sequence">CTATCGTTATCATGGACACGCTATGAGCGACCCAGGAGTCAGCGCCCGCACACGTGAGGAGA</named-content>-3’ and reverse 5’- <named-content content-type="sequence">TTCCCTCACGTGTGCGGGCGCTGACTCCTGGGTCGCTCATAGCGTGTCCATGATAACGATAG</named-content>-3’). Plasmids were then injected into one-cell stage embryos with I-SceI (NEB) or <italic>Tol2</italic> mRNA.</p></sec><sec id="s4-2"><title>Quantification of CMs in the trabecular layer</title><p>Quantification of trabecular CMs in 77 and 81 hpf heats was performed as previously described (<xref ref-type="bibr" rid="bib24">Jiménez-Amilburu et al., 2016</xref>) using the ZEN software (ZEISS). Starting from the mid-sagittal plane, we quantified trabecular versus compact layer CMs in the ventricular outer curvature, 12 planes up and 12 planes down at an increment of 1 μm per plane. To quantify donor-derived trabecular CMs in chimeric hearts generated by cell transplantation, we counted the number of donor-derived trabecular and compact layer CMs. Then, the percentage of donor-derived trabecular CMs was calculated by dividing the number of donor-derived trabecular CMs by the total number of donor-derived CMs. Quantification of trabecular CMs in 131 hpf hearts was performed using the ZEN software (ZEISS). Starting from the mid-sagittal plane, we measured the whole myocardial area as well as the trabecular area, 10 μm up and 10 μm down. Three different sagittal planes per heart were measured. The percentage of the trabecular area for each sagittal plane was calculated by dividing the trabecular area by the myocardial area, and the average value was used for the graph.</p></sec><sec id="s4-3"><title>In situ hybridization</title><p>In situ hybridization was performed as previously described (<xref ref-type="bibr" rid="bib56">Thisse and Thisse, 2008</xref>). To synthesize <italic>pkma</italic> (NM_199333) and <italic>pkmb</italic> (NM_001003488) RNA probes, the following primers were used to amplify the corresponding DNA fragments: <italic>pkma</italic> (forward 5’- <named-content content-type="sequence">TTGGATCCACCATGTCTCAAACTAAAGCTC</named-content>-3’ and reverse 5’- <named-content content-type="sequence">TTTGAATTCTTACGGCACTGGGACGACAC</named-content>-3’); <italic>pkmb</italic> (forward 5’- <named-content content-type="sequence">TTGGATCCACCATGTCTCAGACAAAGACTA</named-content>-3’ and reverse 5’- <named-content content-type="sequence">TTTGAATTCTCAAGGCACCACAACGATG</named-content>’). The DNA fragments were cloned into the pCS2 vector. DIG-labeled RNA probes were synthesized using a DIG RNA labeling kit (Sigma-Aldrich) and MegaScript T7 Transcription Kit (Thermo Fisher Scientific).</p></sec><sec id="s4-4"><title>Pharmacological treatments</title><p>Zebrafish embryos were treated with DMSO (control), 30 mM DCA (Sigma-Aldrich) or 5 μM Erbb2 inhibitor (AG1478; Sigma-Aldrich) from 50 hpf to 77 hpf and then analyzed.</p></sec><sec id="s4-5"><title>TUNEL assay</title><p>To examine apoptosis, an in situ cell death detection kit (Roche) was used.</p></sec><sec id="s4-6"><title>Immunostaining</title><p>Rat neonatal CMs were fixed in 4% paraformaldehyde. Anti-cardiac troponin I (CTNI) 1:500 (ab56357, Abcam) and anti-PKM2 1:100 (D78A4, Cell Signaling) were used. After washing with PBS, samples were stained with Alexa-568, Alexa-488 or Alexa-647 secondary antibodies 1:500 (Life Technologies), followed by 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) 1:2000 (Merck) staining to visualize DNA.</p></sec><sec id="s4-7"><title>Cell culture</title><p>Rat neonatal (P2-P4) CMs were isolated and cultured as previously described (<xref ref-type="bibr" rid="bib15">Fukuda et al., 2017</xref>). Cells were plated onto 0.1% gelatin-coated (Sigma) plates and cultured in DMEM/F12 (Gibco) supplemented with 5% horse serum, L-glutamine, Na-pyruvate, penicillin and streptomycin at 37°C and 5% CO<sub>2</sub>. Adenovirus vectors for transfection into CMs were generated using the AdEasy system (Agilent Technologies). To generate adenovirus vectors encoding PDK3 (NM_001106581) or ERBB2 (NM_004448), the following primers were used to amplify <italic>Pdk3</italic> from rat neonatal CM or <italic>ERBB2</italic> from Addgene clone # 39321: <italic>Pdk3</italic> (forward 5’-<named-content content-type="sequence">TAGAGATCTGGTACCGTCGACCACCATGCGGCTCTTCTACCG</named-content>-3’ and reverse 5’-<named-content content-type="sequence">GGATATCTTATCTAGAAGCTTCTAGAAAGTTTTATTACTCTTGATCTTGTCC</named-content>-3’); <italic>ERBB2</italic> (forward 5’-<named-content content-type="sequence">TAGAGATCTGGTACCGTCGACGCGGCCGCACCACCATGTATCCATATGATGTTCCAGATTATGCTATGGAGCTGGCGGCCTTG</named-content>-3’ and reverse 5’-<named-content content-type="sequence">GGATATCTTATCTAGAAGCTTTCACACTGGCACGTCCAG</named-content>).</p></sec><sec id="s4-8"><title>Imaging</title><p>Zebrafish embryos and larvae were anesthetized with 0.2% tricaine and mounted in 1% low-melting agarose. A Zeiss spinning disk confocal microscope system (CSU-X1, Yokogawa) and ORCA-flash4.0 sCMOS camera (Hamamatsu) was used to acquire images. 3D images were processed using Imaris (Bitplane). Circularity was measured using ImageJ (NIH).</p></sec><sec id="s4-9"><title>Western blotting</title><p>Protein expression levels were analyzed by western blotting as previously described (<xref ref-type="bibr" rid="bib15">Fukuda et al., 2017</xref>). In brief, proteins were extracted with lysis buffer (150 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.2% SDS, 1 mM EDTA, 5 mM NaF, 0.1 mM orthovanadate, 1 mM phenylmethylsulfonyl fluoride and 1 μg/ml aprotinin). Proteins were separated by SDS-PAGE. The following primary antibodies were used: anti-PKM2 1:1000 (D78A4, Cell Signaling) and anti-alpha-Tubulin 1:1000 (T6199, Sigma).</p></sec><sec id="s4-10"><title>qPCR</title><p>Rat neonatal CMs were transfected with adenovirus vectors encoding genes of interest. 24 hr after transfection, total RNA was extracted. Zebrafish embryos and larvae were treated with DMSO or Erbb2 inhibitor from 55 to 106 hpf, and then the hearts were isolated to extract total RNA. A miRNeasy Mini kit (Qiagen) was used for total RNA extraction and cDNA was synthesized using a SuperScript Second Strand kit (Life Technologies). A CFX Connect Real-Time system (Bio-Rad) and DyNAmo colorFlash SYBR green qPCR kit (ThermoFisher Scientific) were used. Primer sequences are shown in <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref> and Ct values in <xref ref-type="supplementary-material" rid="fig2sdata3">Figure 2—source data 3</xref>.</p></sec><sec id="s4-11"><title>Metabolic assays</title><p>The extracellular acidification rate (ECAR) was measured using a Seahorse XFe96 analyzer (Seahorse Bioscience) following manufacturer’s protocol. Rat neonatal CMs were seeded at 30,000 cells/well on to 0.1% gelatin-coated XFe96 microplates (Agilent Technologies) in DMEM/F12 (Gibco) containing 10% fetal bovine serum (FBS), L-glutamine, Na-pyruvate, penicillin and streptomycin at 37°C and 5% CO<sub>2</sub>. After 24 hr of culture, the medium was replaced with serum-free medium. Then, cells were transfected with adenovirus vectors encoding genes of interest or a mock adenovirus vector, or treated with NRG1 (100 ng/ml; Abcam). 24 hr after transfection or NRG1 treatment, cells were maintained in non-buffered assay medium (Agilent Technologies) in a non-CO<sub>2</sub> incubator 1 hr prior to the assay. A glycolysis stress test kit (Seahorse Bioscience) was used to monitor ECAR where baseline measurements were made followed by sequential injection of glucose (10 mM), oligomycin (2 μM), and 2-DG (100 mM).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Beate Grohmann, Radhan Ramadass, Srinath Ramkumar, Simon Perathoner, Carmen Büttner, Nana Fukuda and Sharon Meaney-Gardian for help and support, Arica Beisaw, Ruben Marin-Juez, Josephine Gollin and Rashmi Priya for comments on the manuscript, and Jeroen Bakkers for communication. This work was supported in part by funds from the Max Planck Society to DYRS.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Project administration</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con5"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con8"><p>Resources</p></fn><fn fn-type="con" id="con9"><p>Supervision</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All zebrafish husbandry was performed under standard conditions in accordance with institutional (MPG) and national ethical and animal welfare guidelines approved by the ethics committee for animal experiments at the Regional Board of Darmstadt, Germany (permit numbers B2/1017, B2/1041 and B2/1159).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-50161-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data in this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>RL</given-names></name><name><surname>Paw</surname> <given-names>I</given-names></name><name><surname>Dewhirst</surname> <given-names>MW</given-names></name><name><surname>Lo</surname> <given-names>H-W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial–mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells</article-title><source>Oncogene</source><volume>34</volume><fpage>546</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.582</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherian</surname> <given-names>AV</given-names></name><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Augustine</surname> <given-names>SM</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>N-cadherin relocalization during cardiac trabeculation</article-title><source>PNAS</source><volume>113</volume><fpage>7569</fpage><lpage>7574</lpage><pub-id pub-id-type="doi">10.1073/pnas.1606385113</pub-id><pub-id pub-id-type="pmid">27339140</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Shaw</surname> <given-names>RM</given-names></name><name><surname>De Val</surname> <given-names>S</given-names></name><name><surname>Kang</surname> <given-names>G</given-names></name><name><surname>Jan</surname> <given-names>LY</given-names></name><name><surname>Black</surname> <given-names>BL</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Foxn4 directly regulates tbx2b expression and atrioventricular canal formation</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1101/gad.1629408</pub-id><pub-id pub-id-type="pmid">18347092</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christofk</surname> <given-names>HR</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Asara</surname> <given-names>JM</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pyruvate kinase M2 is a phosphotyrosine-binding protein</article-title><source>Nature</source><volume>452</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1038/nature06667</pub-id><pub-id pub-id-type="pmid">18337815</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corfas</surname> <given-names>G</given-names></name><name><surname>Rosen</surname> <given-names>KM</given-names></name><name><surname>Aratake</surname> <given-names>H</given-names></name><name><surname>Krauss</surname> <given-names>R</given-names></name><name><surname>Fischbach</surname> <given-names>GD</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Differential expression of ARIA isoforms in the rat brain</article-title><source>Neuron</source><volume>14</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(95)90244-9</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amico</surname> <given-names>L</given-names></name><name><surname>Scott</surname> <given-names>IC</given-names></name><name><surname>Jungblut</surname> <given-names>B</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A mutation in zebrafish hmgcr1b reveals a role for isoprenoids in vertebrate Heart-Tube formation</article-title><source>Current Biology</source><volume>17</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.12.023</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBerardinis</surname> <given-names>RJ</given-names></name><name><surname>Lum</surname> <given-names>JJ</given-names></name><name><surname>Hatzivassiliou</surname> <given-names>G</given-names></name><name><surname>Thompson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The biology of Cancer: metabolic reprogramming fuels cell growth and proliferation</article-title><source>Cell Metabolism</source><volume>7</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.10.002</pub-id><pub-id pub-id-type="pmid">18177721</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejana</surname> <given-names>E</given-names></name><name><surname>Hirschi</surname> <given-names>KK</given-names></name><name><surname>Simons</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The molecular basis of endothelial cell plasticity</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14361</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14361</pub-id><pub-id pub-id-type="pmid">28181491</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Monte-Nieto</surname> <given-names>G</given-names></name><name><surname>Ramialison</surname> <given-names>M</given-names></name><name><surname>Adam</surname> <given-names>AAS</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Aharonov</surname> <given-names>A</given-names></name><name><surname>D'Uva</surname> <given-names>G</given-names></name><name><surname>Bourke</surname> <given-names>LM</given-names></name><name><surname>Pitulescu</surname> <given-names>ME</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>de la Pompa</surname> <given-names>JL</given-names></name><name><surname>Shou</surname> <given-names>W</given-names></name><name><surname>Adams</surname> <given-names>RH</given-names></name><name><surname>Harten</surname> <given-names>SK</given-names></name><name><surname>Tzahor</surname> <given-names>E</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Harvey</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation</article-title><source>Nature</source><volume>557</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0110-6</pub-id><pub-id pub-id-type="pmid">29743679</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doenst</surname> <given-names>T</given-names></name><name><surname>Nguyen</surname> <given-names>TD</given-names></name><name><surname>Abel</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cardiac metabolism in heart failure: implications beyond ATP production</article-title><source>Circulation Research</source><volume>113</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.300376</pub-id><pub-id pub-id-type="pmid">23989714</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Uva</surname> <given-names>G</given-names></name><name><surname>Aharonov</surname> <given-names>A</given-names></name><name><surname>Lauriola</surname> <given-names>M</given-names></name><name><surname>Kain</surname> <given-names>D</given-names></name><name><surname>Yahalom-Ronen</surname> <given-names>Y</given-names></name><name><surname>Carvalho</surname> <given-names>S</given-names></name><name><surname>Weisinger</surname> <given-names>K</given-names></name><name><surname>Bassat</surname> <given-names>E</given-names></name><name><surname>Rajchman</surname> <given-names>D</given-names></name><name><surname>Yifa</surname> <given-names>O</given-names></name><name><surname>Lysenko</surname> <given-names>M</given-names></name><name><surname>Konfino</surname> <given-names>T</given-names></name><name><surname>Hegesh</surname> <given-names>J</given-names></name><name><surname>Brenner</surname> <given-names>O</given-names></name><name><surname>Neeman</surname> <given-names>M</given-names></name><name><surname>Yarden</surname> <given-names>Y</given-names></name><name><surname>Leor</surname> <given-names>J</given-names></name><name><surname>Sarig</surname> <given-names>R</given-names></name><name><surname>Harvey</surname> <given-names>RP</given-names></name><name><surname>Tzahor</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation</article-title><source>Nature Cell Biology</source><volume>17</volume><fpage>627</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1038/ncb3149</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellen Kreipke</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Miklas</surname> <given-names>JW</given-names></name><name><surname>Mathieu</surname> <given-names>J</given-names></name><name><surname>Ruohola-Baker</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic remodeling in early development and cardiomyocyte maturation</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>52</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2016.02.004</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahed</surname> <given-names>AC</given-names></name><name><surname>Gelb</surname> <given-names>BD</given-names></name><name><surname>Seidman</surname> <given-names>JG</given-names></name><name><surname>Seidman</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetics of congenital heart disease: the glass half empty</article-title><source>Circulation Research</source><volume>112</volume><fpage>707</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300853</pub-id><pub-id pub-id-type="pmid">23410880</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Kang</surname> <given-names>HB</given-names></name><name><surname>Shan</surname> <given-names>C</given-names></name><name><surname>Elf</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>R</given-names></name><name><surname>Xie</surname> <given-names>J</given-names></name><name><surname>Gu</surname> <given-names>TL</given-names></name><name><surname>Aguiar</surname> <given-names>M</given-names></name><name><surname>Lonning</surname> <given-names>S</given-names></name><name><surname>Chung</surname> <given-names>TW</given-names></name><name><surname>Arellano</surname> <given-names>M</given-names></name><name><surname>Khoury</surname> <given-names>HJ</given-names></name><name><surname>Shin</surname> <given-names>DM</given-names></name><name><surname>Khuri</surname> <given-names>FR</given-names></name><name><surname>Boggon</surname> <given-names>TJ</given-names></name><name><surname>Kang</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the warburg effect</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>26533</fpage><lpage>26541</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.593970</pub-id><pub-id pub-id-type="pmid">25104357</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Gunawan</surname> <given-names>F</given-names></name><name><surname>Beisaw</surname> <given-names>A</given-names></name><name><surname>Jimenez-Amilburu</surname> <given-names>V</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Kostin</surname> <given-names>S</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Proteolysis regulates cardiomyocyte maturation and tissue integration</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14495</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14495</pub-id><pub-id pub-id-type="pmid">28211472</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassmann</surname> <given-names>M</given-names></name><name><surname>Casagranda</surname> <given-names>F</given-names></name><name><surname>Orioli</surname> <given-names>D</given-names></name><name><surname>Simon</surname> <given-names>H</given-names></name><name><surname>Lai</surname> <given-names>C</given-names></name><name><surname>Klein</surname> <given-names>R</given-names></name><name><surname>Lemke</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor</article-title><source>Nature</source><volume>378</volume><fpage>390</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/378390a0</pub-id><pub-id pub-id-type="pmid">7477376</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grego-Bessa</surname> <given-names>J</given-names></name><name><surname>Luna-Zurita</surname> <given-names>L</given-names></name><name><surname>del Monte</surname> <given-names>G</given-names></name><name><surname>Bolós</surname> <given-names>V</given-names></name><name><surname>Melgar</surname> <given-names>P</given-names></name><name><surname>Arandilla</surname> <given-names>A</given-names></name><name><surname>Garratt</surname> <given-names>AN</given-names></name><name><surname>Zang</surname> <given-names>H</given-names></name><name><surname>Mukouyama</surname> <given-names>YS</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Shou</surname> <given-names>W</given-names></name><name><surname>Ballestar</surname> <given-names>E</given-names></name><name><surname>Esteller</surname> <given-names>M</given-names></name><name><surname>Rojas</surname> <given-names>A</given-names></name><name><surname>Pérez-Pomares</surname> <given-names>JM</given-names></name><name><surname>de la Pompa</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Notch signaling is essential for ventricular chamber development</article-title><source>Developmental Cell</source><volume>12</volume><fpage>415</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.12.011</pub-id><pub-id pub-id-type="pmid">17336907</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname> <given-names>A</given-names></name><name><surname>Germano</surname> <given-names>RF</given-names></name><name><surname>Stone</surname> <given-names>O</given-names></name><name><surname>Arnaout</surname> <given-names>R</given-names></name><name><surname>Guenther</surname> <given-names>S</given-names></name><name><surname>Ahuja</surname> <given-names>S</given-names></name><name><surname>Uribe</surname> <given-names>V</given-names></name><name><surname>Vanhollebeke</surname> <given-names>B</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Reischauer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Distinct myocardial lineages break atrial symmetry during cardiogenesis in zebrafish</article-title><source>eLife</source><volume>7</volume><elocation-id>e32833</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32833</pub-id><pub-id pub-id-type="pmid">29762122</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunawan</surname> <given-names>F</given-names></name><name><surname>Gentile</surname> <given-names>A</given-names></name><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Tsedeke</surname> <given-names>AT</given-names></name><name><surname>Jiménez-Amilburu</surname> <given-names>V</given-names></name><name><surname>Ramadass</surname> <given-names>R</given-names></name><name><surname>Iida</surname> <given-names>A</given-names></name><name><surname>Sehara-Fujisawa</surname> <given-names>A</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Focal adhesions are essential to drive zebrafish heart valve morphogenesis</article-title><source>The Journal of Cell Biology</source><volume>218</volume><fpage>1039</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1083/jcb.201807175</pub-id><pub-id pub-id-type="pmid">30635353</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitosugi</surname> <given-names>T</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Chung</surname> <given-names>TW</given-names></name><name><surname>Lythgoe</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Xie</surname> <given-names>J</given-names></name><name><surname>Ge</surname> <given-names>Q</given-names></name><name><surname>Gu</surname> <given-names>TL</given-names></name><name><surname>Polakiewicz</surname> <given-names>RD</given-names></name><name><surname>Roesel</surname> <given-names>JL</given-names></name><name><surname>Chen</surname> <given-names>GZ</given-names></name><name><surname>Boggon</surname> <given-names>TJ</given-names></name><name><surname>Lonial</surname> <given-names>S</given-names></name><name><surname>Fu</surname> <given-names>H</given-names></name><name><surname>Khuri</surname> <given-names>FR</given-names></name><name><surname>Kang</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for Cancer metabolism</article-title><source>Molecular Cell</source><volume>44</volume><fpage>864</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.10.015</pub-id><pub-id pub-id-type="pmid">22195962</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honkoop</surname> <given-names>H</given-names></name><name><surname>de Bakker</surname> <given-names>DE</given-names></name><name><surname>Aharonov</surname> <given-names>A</given-names></name><name><surname>Kruse</surname> <given-names>F</given-names></name><name><surname>Shakked</surname> <given-names>A</given-names></name><name><surname>Nguyen</surname> <given-names>PD</given-names></name><name><surname>de Heus</surname> <given-names>C</given-names></name><name><surname>Garric</surname> <given-names>L</given-names></name><name><surname>Muraro</surname> <given-names>MJ</given-names></name><name><surname>Shoffner</surname> <given-names>A</given-names></name><name><surname>Tessadori</surname> <given-names>F</given-names></name><name><surname>Peterson</surname> <given-names>JC</given-names></name><name><surname>Noort</surname> <given-names>W</given-names></name><name><surname>Bertozzi</surname> <given-names>A</given-names></name><name><surname>Weidinger</surname> <given-names>G</given-names></name><name><surname>Posthuma</surname> <given-names>G</given-names></name><name><surname>Grun</surname> <given-names>D</given-names></name><name><surname>van der Laarse</surname> <given-names>WJ</given-names></name><name><surname>Klumperman</surname> <given-names>J</given-names></name><name><surname>Jaspers</surname> <given-names>RT</given-names></name><name><surname>Poss</surname> <given-names>KD</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name><name><surname>Tzahor</surname> <given-names>E</given-names></name><name><surname>Bakkers</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart</article-title><source>eLife</source><volume>8</volume><elocation-id>e50163</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.50163</pub-id><pub-id pub-id-type="pmid">31868166</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>R</given-names></name><name><surname>Zong</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Aberrant Cancer metabolism in epithelial-mesenchymal transition and Cancer metastasis: mechanisms in Cancer progression</article-title><source>Critical Reviews in Oncology/Hematology</source><volume>115</volume><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2017.04.005</pub-id><pub-id pub-id-type="pmid">28602165</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingthorsson</surname> <given-names>S</given-names></name><name><surname>Andersen</surname> <given-names>K</given-names></name><name><surname>Hilmarsdottir</surname> <given-names>B</given-names></name><name><surname>Maelandsmo</surname> <given-names>GM</given-names></name><name><surname>Magnusson</surname> <given-names>MK</given-names></name><name><surname>Gudjonsson</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR</article-title><source>Oncogene</source><volume>35</volume><fpage>4244</fpage><lpage>4255</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.489</pub-id><pub-id pub-id-type="pmid">26686087</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiménez-Amilburu</surname> <given-names>V</given-names></name><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>Staudt</surname> <given-names>DW</given-names></name><name><surname>Nakajima</surname> <given-names>H</given-names></name><name><surname>Chiba</surname> <given-names>A</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In Vivo Visualization of Cardiomyocyte Apicobasal Polarity Reveals Epithelial to Mesenchymal-like Transition during Cardiac Trabeculation</article-title><source>Cell Reports</source><volume>17</volume><fpage>2687</fpage><lpage>2699</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.023</pub-id><pub-id pub-id-type="pmid">27926871</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolwicz</surname> <given-names>SC</given-names></name><name><surname>Purohit</surname> <given-names>S</given-names></name><name><surname>Tian</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes</article-title><source>Circulation Research</source><volume>113</volume><fpage>603</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.302095</pub-id><pub-id pub-id-type="pmid">23948585</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koukourakis</surname> <given-names>MI</given-names></name><name><surname>Giatromanolaki</surname> <given-names>A</given-names></name><name><surname>Sivridis</surname> <given-names>E</given-names></name><name><surname>Gatter</surname> <given-names>KC</given-names></name><name><surname>Harris</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung Cancer and Tumor-Associated stroma</article-title><source>Neoplasia</source><volume>7</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1593/neo.04373</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacic</surname> <given-names>JC</given-names></name><name><surname>Dimmeler</surname> <given-names>S</given-names></name><name><surname>Harvey</surname> <given-names>RP</given-names></name><name><surname>Finkel</surname> <given-names>T</given-names></name><name><surname>Aikawa</surname> <given-names>E</given-names></name><name><surname>Krenning</surname> <given-names>G</given-names></name><name><surname>Baker</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Endothelial to mesenchymal transition in Cardiovascular Disease: JACC State-of-the-Art Review</article-title><source>Journal of the American College of Cardiology</source><volume>73</volume><fpage>190</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2018.09.089</pub-id><pub-id pub-id-type="pmid">30654892</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leclerc</surname> <given-names>D</given-names></name><name><surname>Pham</surname> <given-names>DN</given-names></name><name><surname>Lévesque</surname> <given-names>N</given-names></name><name><surname>Truongcao</surname> <given-names>M</given-names></name><name><surname>Foulkes</surname> <given-names>WD</given-names></name><name><surname>Sapienza</surname> <given-names>C</given-names></name><name><surname>Rozen</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oncogenic role of PDK4 in human Colon cancer cells</article-title><source>British Journal of Cancer</source><volume>116</volume><fpage>930</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/bjc.2017.38</pub-id><pub-id pub-id-type="pmid">28208156</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KF</given-names></name><name><surname>Simon</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Bates</surname> <given-names>B</given-names></name><name><surname>Hung</surname> <given-names>MC</given-names></name><name><surname>Hauser</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Requirement for neuregulin receptor erbB2 in neural and cardiac development</article-title><source>Nature</source><volume>378</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/378394a0</pub-id><pub-id pub-id-type="pmid">7477377</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberti</surname> <given-names>MV</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The warburg effect: how does it benefit Cancer cells?</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2015.12.001</pub-id><pub-id pub-id-type="pmid">26778478</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Bressan</surname> <given-names>M</given-names></name><name><surname>Hassel</surname> <given-names>D</given-names></name><name><surname>Huisken</surname> <given-names>J</given-names></name><name><surname>Staudt</surname> <given-names>D</given-names></name><name><surname>Kikuchi</surname> <given-names>K</given-names></name><name><surname>Poss</surname> <given-names>KD</given-names></name><name><surname>Mikawa</surname> <given-names>T</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A dual role for ErbB2 signaling in cardiac trabeculation</article-title><source>Development</source><volume>137</volume><fpage>3867</fpage><lpage>3875</lpage><pub-id pub-id-type="doi">10.1242/dev.053736</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>CW</given-names></name><name><surname>Lin</surname> <given-names>SC</given-names></name><name><surname>Chen</surname> <given-names>KF</given-names></name><name><surname>Lai</surname> <given-names>YY</given-names></name><name><surname>Tsai</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Induction of pyruvate dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 promotes metabolic switch and drug resistance</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>28106</fpage><lpage>28114</lpage><pub-id pub-id-type="doi">10.1074/jbc.M803508200</pub-id><pub-id pub-id-type="pmid">18718909</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunt</surname> <given-names>SY</given-names></name><name><surname>Muralidhar</surname> <given-names>V</given-names></name><name><surname>Hosios</surname> <given-names>AM</given-names></name><name><surname>Israelsen</surname> <given-names>WJ</given-names></name><name><surname>Gui</surname> <given-names>DY</given-names></name><name><surname>Newhouse</surname> <given-names>L</given-names></name><name><surname>Ogrodzinski</surname> <given-names>M</given-names></name><name><surname>Hecht</surname> <given-names>V</given-names></name><name><surname>Xu</surname> <given-names>K</given-names></name><name><surname>Acevedo</surname> <given-names>PN</given-names></name><name><surname>Hollern</surname> <given-names>DP</given-names></name><name><surname>Bellinger</surname> <given-names>G</given-names></name><name><surname>Dayton</surname> <given-names>TL</given-names></name><name><surname>Christen</surname> <given-names>S</given-names></name><name><surname>Elia</surname> <given-names>I</given-names></name><name><surname>Dinh</surname> <given-names>AT</given-names></name><name><surname>Stephanopoulos</surname> <given-names>G</given-names></name><name><surname>Manalis</surname> <given-names>SR</given-names></name><name><surname>Yaffe</surname> <given-names>MB</given-names></name><name><surname>Andrechek</surname> <given-names>ER</given-names></name><name><surname>Fendt</surname> <given-names>SM</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation</article-title><source>Molecular Cell</source><volume>57</volume><fpage>95</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.10.027</pub-id><pub-id pub-id-type="pmid">25482511</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunt</surname> <given-names>SY</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Aerobic glycolysis: meeting the metabolic requirements of cell proliferation</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>27</volume><fpage>441</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154237</pub-id><pub-id pub-id-type="pmid">21985671</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mably</surname> <given-names>JD</given-names></name><name><surname>Mohideen</surname> <given-names>MA</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Heart of glass regulates the concentric growth of the heart in zebrafish</article-title><source>Current Biology</source><volume>13</volume><fpage>2138</fpage><lpage>2147</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2003.11.055</pub-id><pub-id pub-id-type="pmid">14680629</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markwald</surname> <given-names>RR</given-names></name><name><surname>Fitzharris</surname> <given-names>TP</given-names></name><name><surname>Manasek</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Structural development of endocardial cushions</article-title><source>American Journal of Anatomy</source><volume>148</volume><fpage>85</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1002/aja.1001480108</pub-id><pub-id pub-id-type="pmid">842477</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>D</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Multiple essential functions of neuregulin in development</article-title><source>Nature</source><volume>378</volume><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/378386a0</pub-id><pub-id pub-id-type="pmid">7477375</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Shieh</surname> <given-names>D</given-names></name><name><surname>Mazurkiewicz</surname> <given-names>JE</given-names></name><name><surname>Barroso</surname> <given-names>M</given-names></name><name><surname>Schwarz</surname> <given-names>JJ</given-names></name><name><surname>Xin</surname> <given-names>HB</given-names></name><name><surname>Singer</surname> <given-names>HA</given-names></name><name><surname>Vincent</surname> <given-names>PA</given-names></name><name><surname>Zhong</surname> <given-names>W</given-names></name><name><surname>Radice</surname> <given-names>GL</given-names></name><name><surname>Wan</surname> <given-names>LQ</given-names></name><name><surname>Fan</surname> <given-names>ZC</given-names></name><name><surname>Huang</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cardiomyocyte orientation modulated by the numb family proteins-N-cadherin Axis is essential for ventricular wall morphogenesis</article-title><source>PNAS</source><volume>116</volume><fpage>15560</fpage><lpage>15569</lpage><pub-id pub-id-type="doi">10.1073/pnas.1904684116</pub-id><pub-id pub-id-type="pmid">31300538</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorman</surname> <given-names>AF</given-names></name><name><surname>Christoffels</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cardiac chamber formation: development, genes, and evolution</article-title><source>Physiological Reviews</source><volume>83</volume><fpage>1223</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1152/physrev.00006.2003</pub-id><pub-id pub-id-type="pmid">14506305</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morandi</surname> <given-names>A</given-names></name><name><surname>Taddei</surname> <given-names>ML</given-names></name><name><surname>Chiarugi</surname> <given-names>P</given-names></name><name><surname>Giannoni</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Targeting the metabolic reprogramming that controls Epithelial-to-Mesenchymal transition in aggressive tumors</article-title><source>Frontiers in Oncology</source><volume>7</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2017.00040</pub-id><pub-id pub-id-type="pmid">28352611</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epithelial plasticity: a common theme in embryonic and Cancer cells</article-title><source>Science</source><volume>342</volume><elocation-id>1234850</elocation-id><pub-id pub-id-type="doi">10.1126/science.1234850</pub-id><pub-id pub-id-type="pmid">24202173</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Plasticity of adult endothelium: how frequent and to what extent?</article-title><source>Cardiovascular Research</source><volume>108</volume><fpage>319</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvv240</pub-id><pub-id pub-id-type="pmid">26490741</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname> <given-names>K</given-names></name><name><surname>Angelini</surname> <given-names>PD</given-names></name><name><surname>Laos</surname> <given-names>S</given-names></name><name><surname>Bach-Faig</surname> <given-names>A</given-names></name><name><surname>Cunningham</surname> <given-names>MP</given-names></name><name><surname>Ferrer-Ramón</surname> <given-names>C</given-names></name><name><surname>Luque-García</surname> <given-names>A</given-names></name><name><surname>García-Castillo</surname> <given-names>J</given-names></name><name><surname>Parra-Palau</surname> <given-names>JL</given-names></name><name><surname>Scaltriti</surname> <given-names>M</given-names></name><name><surname>Ramón y Cajal</surname> <given-names>S</given-names></name><name><surname>Baselga</surname> <given-names>J</given-names></name><name><surname>Arribas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>3319</fpage><lpage>3331</lpage><pub-id pub-id-type="doi">10.1128/MCB.01803-08</pub-id><pub-id pub-id-type="pmid">19364815</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>J-H</given-names></name><name><surname>Fan</surname> <given-names>W-J</given-names></name><name><surname>Meng</surname> <given-names>Y-T</given-names></name><name><surname>Li</surname> <given-names>M-M</given-names></name><name><surname>Li</surname> <given-names>T-T</given-names></name><name><surname>Cui</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>H-F</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>An</surname> <given-names>F</given-names></name><name><surname>Guo</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>X-F</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Lv</surname> <given-names>L</given-names></name><name><surname>Lv</surname> <given-names>D-K</given-names></name><name><surname>Xu</surname> <given-names>L-Z</given-names></name><name><surname>Xie</surname> <given-names>J-J</given-names></name><name><surname>Lin</surname> <given-names>W-X</given-names></name><name><surname>Lam</surname> <given-names>EW-F</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Glycolysis gatekeeper PDK1 reprograms breast Cancer stem cells under hypoxia</article-title><source>Oncogene</source><volume>37</volume><fpage>1062</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1038/onc.2017.368</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppicelli</surname> <given-names>S</given-names></name><name><surname>Bianchini</surname> <given-names>F</given-names></name><name><surname>Torre</surname> <given-names>E</given-names></name><name><surname>Calorini</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells</article-title><source>Clinical &amp; Experimental Metastasis</source><volume>31</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1007/s10585-014-9637-6</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peshkovsky</surname> <given-names>C</given-names></name><name><surname>Totong</surname> <given-names>R</given-names></name><name><surname>Yelon</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dependence of cardiac trabeculation on neuregulin signaling and blood flow in zebrafish</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>446</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22526</pub-id><pub-id pub-id-type="pmid">21246662</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potente</surname> <given-names>M</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The link between angiogenesis and endothelial metabolism</article-title><source>Annual Review of Physiology</source><volume>79</volume><fpage>43</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-105134</pub-id><pub-id pub-id-type="pmid">27992732</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of cardiomyocyte behavior in zebrafish trabeculation by neuregulin 2a signaling</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15281</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15281</pub-id><pub-id pub-id-type="pmid">28485381</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reischauer</surname> <given-names>S</given-names></name><name><surname>Arnaout</surname> <given-names>R</given-names></name><name><surname>Ramadass</surname> <given-names>R</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Actin binding GFP allows 4D in vivo imaging of myofilament dynamics in the zebrafish heart and the identification of Erbb2 signaling as a remodeling factor of myofibril architecture</article-title><source>Circulation Research</source><volume>115</volume><fpage>845</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.304356</pub-id><pub-id pub-id-type="pmid">25228389</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Soria</surname> <given-names>P</given-names></name><name><surname>Camenisch</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ErbB signaling in cardiac development and disease</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>21</volume><fpage>929</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2010.09.011</pub-id><pub-id pub-id-type="pmid">20933094</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedmera</surname> <given-names>D</given-names></name><name><surname>Pexieder</surname> <given-names>T</given-names></name><name><surname>Vuillemin</surname> <given-names>M</given-names></name><name><surname>Thompson</surname> <given-names>RP</given-names></name><name><surname>Anderson</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Developmental patterning of the myocardium</article-title><source>The Anatomical Record</source><volume>258</volume><fpage>319</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0185(20000401)258:4&lt;319::AID-AR1&gt;3.0.CO;2-O</pub-id><pub-id pub-id-type="pmid">10737851</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudt</surname> <given-names>DW</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Thorn</surname> <given-names>KS</given-names></name><name><surname>Stuurman</surname> <given-names>N</given-names></name><name><surname>Liebling</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>High-resolution imaging of cardiomyocyte behavior reveals two distinct steps in ventricular trabeculation</article-title><source>Development</source><volume>141</volume><fpage>585</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1242/dev.098632</pub-id><pub-id pub-id-type="pmid">24401373</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudt</surname> <given-names>D</given-names></name><name><surname>Stainier</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Uncovering the molecular and cellular mechanisms of heart development using the zebrafish</article-title><source>Annual Review of Genetics</source><volume>46</volume><fpage>397</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-110711-155646</pub-id><pub-id pub-id-type="pmid">22974299</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>El-Brolosy</surname> <given-names>M</given-names></name><name><surname>Wilhelm</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Romão</surname> <given-names>AM</given-names></name><name><surname>Grillo</surname> <given-names>E</given-names></name><name><surname>Lai</surname> <given-names>JKH</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Jeratsch</surname> <given-names>S</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>IC</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name><name><surname>Santoro</surname> <given-names>MM</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name><name><surname>Potente</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4077</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06406-8</pub-id><pub-id pub-id-type="pmid">30301887</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Quan</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Chu</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Leng</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cardiac-Specific deletion of the <italic>Pdha1</italic> gene sensitizes heart to toxicological actions of ischemic stress</article-title><source>Toxicological Sciences</source><volume>151</volume><fpage>193</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfw035</pub-id><pub-id pub-id-type="pmid">26884059</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname> <given-names>J</given-names></name><name><surname>Greten</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cell plasticity in epithelial homeostasis and tumorigenesis</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/ncb3611</pub-id><pub-id pub-id-type="pmid">28945230</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epithelial-Mesenchymal plasticity: a central regulator of Cancer progression</article-title><source>Trends in Cell Biology</source><volume>25</volume><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2015.07.012</pub-id><pub-id pub-id-type="pmid">26437589</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeisberg</surname> <given-names>EM</given-names></name><name><surname>Tarnavski</surname> <given-names>O</given-names></name><name><surname>Zeisberg</surname> <given-names>M</given-names></name><name><surname>Dorfman</surname> <given-names>AL</given-names></name><name><surname>McMullen</surname> <given-names>JR</given-names></name><name><surname>Gustafsson</surname> <given-names>E</given-names></name><name><surname>Chandraker</surname> <given-names>A</given-names></name><name><surname>Yuan</surname> <given-names>X</given-names></name><name><surname>Pu</surname> <given-names>WT</given-names></name><name><surname>Roberts</surname> <given-names>AB</given-names></name><name><surname>Neilson</surname> <given-names>EG</given-names></name><name><surname>Sayegh</surname> <given-names>MH</given-names></name><name><surname>Izumo</surname> <given-names>S</given-names></name><name><surname>Kalluri</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Endothelial-to-mesenchymal transition contributes to cardiac fibrosis</article-title><source>Nature Medicine</source><volume>13</volume><fpage>952</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1038/nm1613</pub-id><pub-id pub-id-type="pmid">17660828</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Qu</surname> <given-names>X</given-names></name><name><surname>Chang</surname> <given-names>CP</given-names></name><name><surname>Shou</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC)</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>163</volume><fpage>144</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31369</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Hulver</surname> <given-names>MW</given-names></name><name><surname>McMillan</surname> <given-names>RP</given-names></name><name><surname>Cline</surname> <given-names>MA</given-names></name><name><surname>Gilbert</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility</article-title><source>Nutrition &amp; Metabolism</source><volume>11</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/1743-7075-11-10</pub-id><pub-id pub-id-type="pmid">24520982</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G</given-names></name><name><surname>Jeoung</surname> <given-names>NH</given-names></name><name><surname>Burgess</surname> <given-names>SC</given-names></name><name><surname>Rosaaen-Stowe</surname> <given-names>KA</given-names></name><name><surname>Inagaki</surname> <given-names>T</given-names></name><name><surname>Latif</surname> <given-names>S</given-names></name><name><surname>Shelton</surname> <given-names>JM</given-names></name><name><surname>McAnally</surname> <given-names>J</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Harris</surname> <given-names>RA</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Kliewer</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>294</volume><fpage>H936</fpage><lpage>H943</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00870.2007</pub-id><pub-id pub-id-type="pmid">18083902</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Boyer</surname> <given-names>L</given-names></name><name><surname>Jin</surname> <given-names>M</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Hamm</surname> <given-names>M</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Hunter</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title><source>eLife</source><volume>5</volume><elocation-id>e13374</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13374</pub-id><pub-id pub-id-type="pmid">27282387</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50161.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Reviewing Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Burgess</surname><given-names>Shawn</given-names> </name><role>Reviewer</role><aff><institution>National Human Genome Research Institute</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This is an elegant study that asks multiple questions about the roles of metabolism in cardiac wall formation and the initiation of trabeculation. Cell transplantations between different genetic/transgenic backgrounds allows detailed analysis of the behavior of cells at the initiation of trabeculation. Overexpression of constitutively active ERRB2 (OE) resulted in upregulation of glycolytic pathway and activity in mouse transgenics, rat neonatal cardiomyocyte cultures, and downregulation of oxidative phosphorylation pathways; the converse was seen with inhibition of Errb2. Multiple approaches, including cardiomyocyte-specific expression of transgenics in zebrafish and <italic>pkma2; pkmb</italic> double mutants, indicate the importance of glycolysis for initiation of trabeculation, downstream of Errb2.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Metabolic modulation regulates cardiac wall morphogenesis and regeneration in zebrafish&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Marianne Bronner as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Shawn Burgess (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Although all of the reviewers are enthusiastic about the manuscript, they concur that it would be important to drop the regeneration component of the manuscript, which feels a bit added on and is not entirely convincing. Other changes are recommended but non-essential. The full reviews are included below for your information.</p><p><italic>Reviewer #1:</italic></p><p>Fukuda and colleagues have submitted a manuscript describing the role of metabolic shifts in cardiac development and regeneration. The majority of the work focuses on a particular developmental stage where the inner walls of the heart begin forming from the compact layer via delaminating cardiomyocytes (trabeculation). ErbB2 signaling has been shown to be important for this process and modulation of erbb2 activity levels is the starting point for this manuscript. Across three model systems, increases in ErbB2 activity increases genes related to glycolysis and decreases in ErbB2 signaling have matching decreases in genes involved in glycolysis. The authors targeted specific enzymes modulating pyruvate metabolism, a summary of the results are 1) inhibiting pyruvate dehydrogenase kinase decreases CMs, 2) increasing PDK activity increases CMs, 3) increasing pyruvate dehydrogenase activity decreases CMs, 4) decreasing pyruvate kinase decreases CMs. Shifting attention to cardiac regeneration in adult zebrafish, similar roles for metabolic shifts are seen, inhibition of PDK (with DCA) or phosphoglucose isomerase (2DG) reduces regeneration as does loss of PK activity while loss of ppargc1a (involved in mitochondrial biosynthesis) stimulates regeneration. In general, these are well-controlled experiments that add significantly to our understanding of the relationship between metabolic modulation and embryonic morphogenesis.</p><p>There are some problems with conclusions and/or conflicting data that should be addressed.</p><p>1) The authors have focused primarily on enzymes involved in the last steps of glycolysis: the pyruvate dehydrogenase complex (PDC), PDK, and pyruvate kinase (PK). It is true that these enzymes are listed in the glycolysis pathway, but except for PK which does release one ATP molecule, the other enzymes are primarily involved in shunting pyruvate either towards lactic acid (and the pentose phosphate pathway) or into the TCA cycle. This shift point isn't really modulating glycolysis but the choice between aerobic and anaerobic respiration and it may be that pyruvate concentration and/or utilization is the key step they are looking at and not glycolysis per se. I am arguing this point because otherwise the loss of PK activity (<italic>pkma2/pkmb</italic>) resulting in less trabeculation and regeneration appears to conflict with the other observations. Increasing PDK activity pushes pyruvate towards lactate (shunting away from mitochondria) resulting in an increase in trabeculation, blocking PDK activity has the opposite effect, less trabeculation more TCA cycle. The dominant active pyruvate dehydrogenase experiments are also consistent with these results, more PDK activity = less trabeculation. The PK knockouts should also reduce the availability of pyruvate for the mitochondria, yet it results in less trabeculation and less regeneration. Perhaps lactate is a key signaling molecule? This has been shown in neurons for example.</p><p>2) I think the authors need to change the general use of glycolysis throughout the manuscript to specify whether they are talking about anaerobic or aerobic glycolysis. Can the redox state be determined during trabeculation?</p><p><italic>Reviewer #2:</italic></p><p>There are a few questions about the trabeculation results, but overall this part of the study is convincing and an important contribution to the heart development field. In contrast, there are significant concerns about the heart regeneration aspects of the paper.</p><p>1) The interpretation that cardiac regeneration is altered is not convincing. The assays for regeneration were only taken to 5 days post cryo injury (dpci), which is not sufficient time to assess whether regeneration is normal or abnormal. The hearts in any of the experimental cohorts could be slightly delayed and then fully recovered by 30 dpci. There is an additional concern that the recovering fish are heat shocked every day for the first five days up to analysis. The standard in the field is 30- or 60-days post injury, with intermittent time points. I suggest removing the regeneration aspect of this paper. It is just too premature, unsupported conclusions in the title and Abstract could be incorrect.</p><p>2) In Figure 4, cell transplantation is used to generate chimeric hearts is a very useful experiment. I imagine the numbers are in hand, but it would be useful to see them analyzed in a few different ways. Are the total number of trabecular cardiomyocytes decreased in the hearts that received mutant donor cells? Or is it just a shift between the mutant vs. host cells that can contribute to the trabeculae? Figure 4C indicates that the% of cardiomyocytes that are trabecular was decreased in hearts that received homozygous mutant cells. However, it does not tell us whether the cardiomyocytes that are trabecular are from the transplanted or host cells. The legend says 'percentage of donor CMs' However, Figure 4B' appears to show some labeled (transplant) cells that are interior (trabecular), outside the white box. It would be useful to know the number of labeled (transplant) vs. unlabeled (host) cells that are trabecular, to understand whether the effect is cell autonomous or non-autonomous.</p><p>3) In Supplementary Figure 5, it appears that mCherry is also expressed in the epicardium after TAM and HS treatment. If this is the case, interpretation of results will need modification.</p><p><italic>Reviewer #3:</italic></p><p>In this manuscript, Fukuda et al. describe a role for glucose metabolism in not only normal development of the trabeculated myocardium, but also in the successful regeneration of the adult heart. Much is known about metabolic processes in the adult heart; here, the authors present a previously understudied role of glycolysis during development. First, by chimeric analysis to produce a higher-resolution look by live imaging, the authors show that cardiomyocytes elicit changes in cell shape to properly develop a trabeculated myocardium. Furthermore, the authors show Nrg1/Erbb2 signaling is required for trabeculation and activates glycolysis, which regulates development of the trabecular myocardium. Finally, the authors extend their study to adulthood and show that glycolysis is essential for successful dedifferentiation and proliferation of cardiomyocytes in cryoinjured adult hearts by upregulation of glycolytic enzymes at the wound border after injury. Overall, the authors contribute a new understanding of the role of glycolysis in proper heart development and repair.</p><p>1) The authors describe cell shape changes and membrane protrusions of cardiomyocytes to enter the trabecular layer. While the images are that of live embryos, this argument would be strengthened by time-lapse imaging to track the individual cardiomyocytes changing shape and position over time.</p><p>2) Methods used to determine glycolytic activity by assaying extracellular acidification rate should be explained in more detail.</p><p>3) The authors use transplanted double heterozygous and double mutant cells to show double mutant cells cannot incorporate into trabeculae. While these are very careful experiments, the health of these cells after transplantation is a concern. Have the authors scored transplant survival? Or performed a TUNEL assay to ensure the mutant cells are not dying after transplantation? Is delamination the only cellular event (cell motility, shape change, membrane protrusions, etc) that is perturbed?</p><p>4) Ppargc1a regulates genes involved in OXPHOS and are absent from regenerating hearts, but are they present in uninjured hearts by in situ?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50161.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>Reviewer #1:</p><p>[…] There are some problems with conclusions and/or conflicting data that should be addressed.</p><disp-quote content-type="editor-comment"><p>1) The authors have focused primarily on enzymes involved in the last steps of glycolysis: the pyruvate dehydrogenase complex (PDC), PDK, and pyruvate kinase (PK). It is true that these enzymes are listed in the glycolysis pathway, but except for PK which does release one ATP molecule, the other enzymes are primarily involved in shunting pyruvate either towards lactic acid (and the pentose phosphate pathway) or into the TCA cycle. This shift point isn't really modulating glycolysis but the choice between aerobic and anaerobic respiration and it may be that pyruvate concentration and/or utilization is the key step they are looking at and not glycolysis per se. I am arguing this point because otherwise the loss of PK activity (pkma2/pkmb) resulting in less trabeculation and regeneration appears to conflict with the other observations. Increasing PDK activity pushes pyruvate towards lactate (shunting away from mitochondria) resulting in an increase in trabeculation, blocking PDK activity has the opposite effect, less trabeculation more TCA cycle. The dominant active pyruvate dehydrogenase experiments are also consistent with these results, more PDK activity = less trabeculation. The PK knockouts should also reduce the availability of pyruvate for the mitochondria, yet it results in less trabeculation and less regeneration. Perhaps lactate is a key signaling molecule? This has been shown in neurons for example.</p></disp-quote><p>The mammalian <italic>Pkm</italic> gene gives rise to two splice isoforms, <italic>Pkm1</italic> and <italic>Pkm2</italic>. The zebrafish genome contains two <italic>pkm</italic> genes, <italic>pkma</italic> and <italic>pkmb. pkma</italic> encodes both an orthologue of mammalian <italic>Pkm1 (pkma1</italic>) and an orthologue of mammalian <italic>Pkm2 (pkma2</italic>), while <italic>pkmb</italic> encodes only another orthologue of mammalian <italic>Pkm2</italic> (Stone et al., 2018).</p><p>Expression of PKM2 is associated with metabolism of pyruvate to lactate. Loss of PKM2 has been shown to result in compensatory upregulation of PKM1, which drives enhanced mitochondrial metabolism of pyruvate (Christofk et al., 2008; Lunt et al., 2015; Zheng et al., 2016). Therefore, with respect to pyruvate metabolism, the loss of PKM2 mimics blocking PDK activity, whereas the loss of PKM1 mimics enhancing PDK activity. In <italic>pkma2; pkmb</italic> double mutant zebrafish, the <italic>pkma1</italic> isoform, which drives pyruvate metabolism via OXPHOS, remains intact. Thus, in <italic>pkma2; pkmb</italic> double mutant zebrafish we expect a reduction in the metabolism of pyruvate to lactate and an increase in pyruvate oxidation, similar to the situation observed following inhibition of PDK activity. These findings are consistent with the other models that have been analyzed (Christofk et al., 2008; Zheng et al., 2016).</p><p>The revised sentence reads as follows:</p><p>‘We examined <italic>pkma2; pkmb</italic> double mutants in which Pkma1, which drives pyruvate metabolism via OXPHOS, remains intact, and found that loss of <italic>pkma2</italic> and <italic>pkmb</italic> impaired trabeculation (Figure 4—figure supplement 1C).’</p><disp-quote content-type="editor-comment"><p>2) I think the authors need to change the general use of glycolysis throughout the manuscript to specify whether they are talking about anaerobic or aerobic glycolysis.</p></disp-quote><p>Although PKM2 (Christofk et al., 2008) and PDK (Takubo et al., 2013) play an important role during aerobic glycolysis (Vander Heiden et al., 2009; Lunt and Vander Heiden, 2011), we did not assess oxygen levels in our models, and thus prefer to use “glycolysis”.</p><disp-quote content-type="editor-comment"><p>Can the redox state be determined during trabeculation?</p></disp-quote><p>We have now examined the redox state using the cardiomyocyte specific reporter line previously used to examine hydrogen peroxide levels (Panieri et al., 2017). We found no significant difference in reporter activity between compact and trabecular cardiomyocytes during delamination (<xref ref-type="fig" rid="respfig1">Author response image 1</xref>).</p><fig id="respfig1"><label>Author response image 1.</label><caption><title>Redox analysis.</title><p>70 hpf <italic>Tg(myl7:mitochondrial-Rogofp2Orp1)</italic> hearts were examined and 405 nm/488 nm ratios determined for redox state analysis. Relative values of 405 nm/488 nm in compact and trabecular cardiomyocytes are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50161-resp-fig1-v2.tif"/></fig><p>Reviewer #2:</p><disp-quote content-type="editor-comment"><p>There are a few questions about the trabeculation results, but overall this part of the study is convincing and an important contribution to the heart development field. In contrast, there are significant concerns about the heart regeneration aspects of the paper.</p><p>1) The interpretation that cardiac regeneration is altered is not convincing. The assays for regeneration were only taken to 5 days post cryo injury (dpci), which is not sufficient time to assess whether regeneration is normal or abnormal. The hearts in any of the experimental cohorts could be slightly delayed and then fully recovered by 30 dpci. There is an additional concern that the recovering fish are heat shocked every day for the first five days up to analysis. The standard in the field is 30- or 60-days post injury, with intermittent time points. I suggest removing the regeneration aspect of this paper. It is just too premature, unsupported conclusions in the title and Abstract could be incorrect.</p></disp-quote><p>We have now removed the regeneration part from the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2) In Figure 4, cell transplantation is used to generate chimeric hearts is a very useful experiment. I imagine the numbers are in hand, but it would be useful to see them analyzed in a few different ways. Are the total number of trabecular cardiomyocytes decreased in the hearts that received mutant donor cells? Or is it just a shift between the mutant vs. host cells that can contribute to the trabeculae? Figure 4C indicates that the% of cardiomyocytes that are trabecular was decreased in hearts that received homozygous mutant cells. However, it does not tell us whether the cardiomyocytes that are trabecular are from the transplanted or host cells. The legend says 'percentage of donor CMs.' However, Figure 4B' appears to show some labeled (transplant) cells that are interior (trabecular), outside the white box. It would be useful to know the number of labeled (transplant) vs. unlabeled (host) cells that are trabecular, to understand whether the effect is cell autonomous or non-autonomous.</p></disp-quote><p>We have now counted the total number of trabecular cardiomyocytes in the chimeric hearts and no significant differences were observed compared to WT (Figure 4—figure supplement 1D).</p><p>In Figure 4C, we counted the number of donor-derived cardiomyocytes in both the trabecular and compact layers of the chimeric hearts. We then calculated the percentage of donor-derived trabecular CMs by dividing the number of donor-derived trabecular CMs by the total number of donor-derived CMs. To clarify this point we have now modified Figure 4C, its legend and the relevant part of the Materials and methods section in the revised manuscript.</p><p>Together, our data indicate cardiomyocyte-autonomous function of <italic>pkma2</italic> and <italic>pkmb</italic> during trabeculation.</p><disp-quote content-type="editor-comment"><p>3) In Supplementary Figure 5, it appears that mCherry is also expressed in the epicardium after TAM and HS treatment. If this is the case, interpretation of results will need modification.</p></disp-quote><p>We have now removed the regeneration part from the revised manuscript.</p><p>Reviewer #3:</p><disp-quote content-type="editor-comment"><p>[…] 1) The authors describe cell shape changes and membrane protrusions of cardiomyocytes to enter the trabecular layer. While the images are that of live embryos, this argument would be strengthened by time-lapse imaging to track the individual cardiomyocytes changing shape and position over time.</p></disp-quote><p>Time-lapse imaging to track individual cardiomyocytes during trabeculation has been shown in a previous paper (Staudt et al., 2014). However, the 3D morphology of single cardiomyocytes that enter the trabecular layer remains mostly unclear, which is why we examined it.</p><disp-quote content-type="editor-comment"><p>2) Methods used to determine glycolytic activity by assaying extracellular acidification rate should be explained in more detail.</p></disp-quote><p>We have now modified the Materials and methods section in the revised manuscript to address the reviewer’s comment.</p><disp-quote content-type="editor-comment"><p>3) The authors use transplanted double heterozygous and double mutant cells to show double mutant cells cannot incorporate into trabeculae. While these are very careful experiments, the health of these cells after transplantation is a concern. Have the authors scored transplant survival? Or performed a TUNEL assay to ensure the mutant cells are not dying after transplantation?</p></disp-quote><p>We have now performed TUNEL assays and no elevated levels of apoptosis were detected in <italic>pkma2; pkmb</italic> mutant cardiomyocytes in chimeric hearts compared to WT cardiomyocytes (Figure 4—figure supplement 1D).</p><disp-quote content-type="editor-comment"><p>Is delamination the only cellular event (cell motility, shape change, membrane protrusions, etc) that is perturbed?</p></disp-quote><p>NRG/ERBB signaling also regulates cardiomyocyte proliferation (Zhao et al., 1998; Grego-bessa et al., 2007; Bersell et al., 2009; Rasouli and Stainier, 2017). We have now counted the number of proliferating cardiomyocytes during trabeculation and these data indicate that modulation of metabolism does not appear to affect cardiomyocyte proliferation (Figure 3—figure supplement 1B).</p><disp-quote content-type="editor-comment"><p>4) Ppargc1a regulates genes involved in OXPHOS and are absent from regenerating hearts, but are they present in uninjured hearts by in situ?</p></disp-quote><p>We have now removed the regeneration part from the revised manuscript.</p><p><bold>References</bold></p><p>Bersell, K., Arab, S., Haring, B., and Kühn, B. (2009). Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury. Cell 138, 257–270.</p><p>Panieri, E., Millia, C., Santoro, M.M., (2017). Real-time quantification of subcellular H2O2 and glutathione redox potential in living cardiovascular tissues, Free Radic Bio Med, 109, 189-200.</p><p>Takubo, K., Nagamatsu, G., Kobayashi, C.I., Nakamura-Ishizu, A., Kobayashi, H., Ikeda, E., Goda, N., Rahimi, Y., Johnson, R.S., Soga, T., et al. (2013). Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12, 49–61.</p><p>Vander Heiden MG, Cantley LC, Thompson CB. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–33.</p><p>Zhao, Y.Y., Sawyer, D.R., Baliga, R.R., Opel, D.J., Han, X., Marchionni, M.A., and Kelly,</p><p>R.A. (1998). Neuregulins promote survival and growth of cardiac myocytes: Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J. Biol. Chem. 273, 10261–10269.</p></body></sub-article></article>